Oxytocin: Nursing pharmacology

Last updated: January 26, 2022

Oxytocin: Nursing pharmacology

nclex review

nclex review

Diabetes insipidus: Nursing process (ADPIE)
Diabetes insipidus and SIADH: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Psoriasis: Nursing
Psoriasis
Psoriatic arthritis
Respiratory acidosis
Respiratory alkalosis
Metabolic and respiratory alkalosis: Clinical
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical
Respiratory distress syndrome: Pathology review
Metabolic acidosis
Acid-base map and compensatory mechanisms
Vaccinations
Pediatric infectious rashes: Clinical
Vaccinations: Clinical
Mumps virus
Measles virus
Chickenpox (Varicella): Nursing process (ADPIE)
Varicella zoster virus
Bordetella pertussis (Whooping cough)
Erythema multiforme
Parvovirus B19
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Clinical
Systemic lupus erythematosus (SLE): Pathology review
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Movement of water between body compartments
Hyponatremia: Clinical
Necrotizing enterocolitis
Short bowel syndrome (NORD)
Hyperkalemia
Hyperkalemia: Clinical
Potassium homeostasis
Plasma anion gap
Autoimmune polyglandular syndrome type 1 (NORD)
Mycobacterium tuberculosis (Tuberculosis)
Leukodystrophy
Cholesterol metabolism
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Liver anatomy and physiology
Medications for thyroid disorders: Nursing pharmacology
Thyroid storm
Hypothyroidism and thyroiditis: Clinical
Thyroid nodules and thyroid cancer: Pathology review
Thyroid hormones
Erysipelas and cellulitis: Nursing
Staphylococcus epidermidis
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Major depressive disorder
Antipsychotics: Nursing pharmacology
Delirium
Medications to control airway secretions: Nursing pharmacology
Rhinovirus
Bites and stings: Clinical
Sickle cell disease (NORD)
Sickle cell disease: Nursing process (ADPIE)
Chronic kidney disease (CKD): Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Kidney stones: Pathology review
Chronic kidney disease: Clinical
Acute kidney injury: Clinical
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Tonsillitis: Nursing process (ADPIE)
Epstein-Barr virus (Infectious mononucleosis)
Adenovirus
Calcium-channel blockers: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Phosphate, calcium and magnesium homeostasis
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Alpha-1 adrenergic blockers: Nursing pharmacology
Oxytocin: Nursing pharmacology
Nitrates: Nursing pharmacology
Vaccines: Nursing pharmacology
Antiemetics: Nursing pharmacology
Insulin: Nursing pharmacology
Hemostatics: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antacids: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antihistamines: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Biologic agents: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Tocolytics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Blood products: Nursing pharmacology
Graves disease
Hirschsprung disease

Notes

OXYTOCIN
DRUG NAME
oxytocin (Pitocin)
CLASS
Uterine stimulant, oxytocic
*High Alert Medication*
MECHANISM OF ACTION
  • Increases intracellular calcium in uterine smooth muscle, which causes uterine muscle contraction
  • Causes contraction of the myoepithelial cells around milk-containing alveoli, resulting in milk ejection during lactation
INDICATIONS
  • Induce or augment labor
  • Control postpartum bleeding
  • Manage incomplete or inevitable abortion
ROUTE(S) OF ADMINISTRATION
  • IV
  • IM
  • NAS
SIDE EFFECTS
  • Uterine hyperstimulation 
  • Nausea, vomiting
  • Hypertension
  • Cardiac arrhythmias
  • Amniotic fluid embolism
  • Water intoxication
CONTRAINDICATIONS AND CAUTIONS
Contraindications / avoid use of oxytocin
  • Cephalopelvic disproportion
  • Fetal malpresentation
  • Umbilical cord prolapse
  • Non-reassuring fetal status
  • Active genital herpes
  • Hypertonic uterus
  • Unripe cervix
  • Grand multiparity
  • Uterine prolapse
  • Clients at risk of uterine rupture
Avoid use in clients receiving vasopressors or prostaglandins like carboprost

Boxed warning: Should be used for medical rather than elective reasons
OXYTOCIN: NURSING CONSIDERATIONS
OXYTOCIN ADMINISTRATION DURING LABOR
  • Start a primary line with 1000 mL IV fluid, e.g. LR
  • Start a second line with standardized concentration of oxytocin in IV fluid
  • Ensure the bags and tubing are labeled clearly
  • Insert oxytocin infusion into mainline IV by connect to port nearest to IV insertion site
  • ALWAYS administer oxytocin via infusion pump
  • Titrate infusion according to client and fetal response
  • Document the start time, end time, dose, and any changes made during administration
MONITORING
  • VS and I&O
  • Frequency, duration, and force of contractions; resting uterine tone
  • FHR pattern
  • Side effects; uterine hyperstimulation; e.g., tachysystole (excessively frequent uterine contractions), uterine tetany (excessively long contractions), nausea, hypertension
  • Signs / symptoms of water intoxication; e.g., headache, irritability, confusion, nausea
UTERINE HYPERSTIMULATION OR ABNORMAL (CATEGORY III) FHR
  1. Immediately stop the infusion
  2. Turn the client on their side, stay with them while you ask another nurse to notify the HCP
  3. Increase the rate of the mainline IV fluid (NOT the fluid containing oxytocin)
  4. Provide supplemental oxygen at 8–10 L/min via face mask
  5. Assess VS and FHR
  6. Document your findings, interventions, and client’s response
OXYTOCIN ADMINISTRATION DURING POSTPARTUM
  • Administer IV or IM
  • Closely monitor fundal tone, fundal height, and position; vital signs, pain, and bleeding
CLIENT EDUCATION
  • Provide client education about how oxytocin will affect their contractions
  • Report headache, dizziness, palpitations, or intense pain
Author: Jannah Amiel, MS, BSN, RN
Author: Lisa Miklush, PhD, RN, CNS
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Oxytocin is a peptide hormone released by the posterior pituitary that causes uterine muscle contraction during labor. It’s also responsible for the milk let-down reflex where milk is ejected during breastfeeding.

It’s commonly used to induce labor or help strengthen uterine contractions to facilitate delivery. After delivery of the placenta, it’s used to treat uterine atony, prevent postpartum hemorrhage and to manage incomplete or inevitable spontaneous abortion.

Okay, a synthetic version of oxytocin is used clinically. To induce labor or strengthen contractions, it’s administered via IV.

After reaching the uterus, it will activate receptors on smooth muscle cells and trigger calcium ion release from the sarcoplasmic reticulum.

This increase in intracellular calcium will cause the muscle to contract harder with increased frequency and duration in order to help with the delivery.

When used postpartum, the uterine contractions will squeeze intrauterine vessels to slow or stop postpartum hemorrhage.

Now, when oxytocin is administered as a nasal spray it causes contraction of the myoepithelial cells around milk-containing alveoli in the breasts. This will squeeze the milk into the lactiferous ducts where it could be ejected during lactation.

The main adverse effects of oxytocin are related to uterine hyperstimulation, where there’s too much contraction. This could cause painful contractions, and lead to uterine rupture and hemorrhage. It could even restrict placental blood flow, resulting in abnormal fetal heart rate patterns.

Other side effects include nausea, vomiting, hypertension, cardiac arrhythmias and amniotic fluid embolism. With prolonged use, it could have an effect similar to antidiuretic hormone and increases water retention. This is particularly dangerous since it could cause water toxicity and result in coma or even death.

Oxytocin is contraindicated or used with caution when vaginal delivery could increase the risk of complications. Common contraindications include the presence of non-reassuring fetal status, in fetal prematurity where the lungs are not fully developed, cephalopelvic disproportion, cervical cancer, active genital herpes infection, unfavorable fetal position, placenta previa, vasa previa, and any other obstetric emergencies that could require surgical intervention.

It should also be avoided in those with grand multiparity, meaning they’ve given birth 5 or more times, and those with uterine prolapse, or at risk of uterine rupture, like clients with 2 or more previous cesarean births.

Finally, it should not be used if the client is receiving a vasopressor like phenylephrine, since both can increase blood pressure.

Now, nurses are responsible for safely administering oxytocin during labor, avoiding excessive stimulation to the uterus or harm to the fetus. So, before starting the infusion, be sure to review the client’s medical record to be sure there are no contraindications to administration.

Assess the cervix to ensure it is ripe, meaning that it has started to change from being firm and thick to soft and thin. Then, confirm that the fetal presentation is favorable for vaginal delivery, and that the estimated fetal gestational age is known.

In addition, assess the fetal status by determining the baseline fetal heart rate or FHR variability, and the presence of accelerations or decelerations.

Finally, teach the client about what to expect as far as contraction strength, duration, and frequency, review measures used to monitor maternal and fetal well-being, and stress the importance of promptly reporting if pain, nausea, or other unpleasant symptoms occur.

Sources

  1. "Karch’s Focus on Nursing Pharmacology. 9th edition. ISBN: 978-1-975180-40-9" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach. 9th edition. ISBN: 978-0-323-39916-6 " Elsevier Canada (2020)
  3. "Lewis’s Medical-Surgical Nursing: Assessment and Management of Clinical Problems. 11th Edition. ISBN: 978-0-323-55149-6 " Mosby (2019)
  4. "Saunders Comprehensive Review for the NCLEX-RN. 9th Edition. ISBN: 978-0-323-79530-2" Saunders (2022)
  5. "Perinatal Nursing. 5th edition. ISBN: 978-1-975174-53-8 " Wolters Kluwer (2020)
  6. "Mosby’s 2023 Nursing Drug Reference. 36th edition. ISBN: 978-0-323-93072-7" Mosby (2022)
  7. "Oxytocin and postpartum depression: A systematic review. 120:104793" Psychoneuroendocrinology (2020)
  8. "Review of Evidence-Based Methods for Successful Labor Induction. 66(4):459-469" J Midwifery Womens Health (2021)